TBScience abstract submissions are open from 14 May to 10 June 2025.

TBScience focuses on the following research areas, for which abstracts will be considered: basic science (microbiology, immunology, cell biology, etc.), animal models, clinical, particularly investigational medicine and product development, and modelling for epidemiology and transmission.

TBScience does not focus on the following research areas, for which abstracts will not be considered: implementation science, health systems and policy, operational and programmatic, descriptive epidemiology (e.g., prevalence surveys), health economics, social science.

IMPORTANT NOTE FOR ABSTRACT SUBMITTERS

This year we invite submission of all abstracts, irrespective of the conference themes. Oral abstract presentations will be offered to authors of the highest-scoring abstracts in the review process. Please check the abstract submission criteria listed below.

2025 Themes

Theme 1:
New frontiers in TB treatment development and monitoring

Description: Many TB patients are treated for longer than necessary, while others are undertreated. Time to sputum culture conversion for monitoring treatment response has limitations. This session will explore advances in biomarkers of treatment response that could accelerate drug development, through faster trials. Other key innovations in TB drug development will also be explored, including strategies to optimize regimen duration, and mitigate resistance risks.

Theme 2:
Artificial Intelligence advancing the TB field

Description: Artificial intelligence has the potential to accelerate discovery and development of drugs, vaccines and diagnostics, by guiding structural design, preclinical testing and clinical trial design. AI could also be applied to TB management throughout the cascade of care. This session will explore the use cases for AI, where tools are already making a difference, and what the future opportunities – and potential risks – are. 

Theme 3:
TB vaccines and other prevention strategies

Description: The TB pandemic will not be controlled without optimal prevention strategies. This session will address the latest advances in TB vaccines, including correlates of protection. Alternative prevention strategies such as long-acting antimicrobials and nutritional intervention will be explored. 

Theme 4:
Microscopic frontiers in TB pathology

Description: The cellular and molecular pathways at the TB infection site will be explored. It is proposed that minute changes can determine clinical trajectories such as lack of disease, asymptomatic or symptomatic disease and long-term sequelae. We will address how understanding of TB pathology could lead to actionable strategies to improve patient outcomes.

Abstract Submission Guidelines

Online abstract submissions are open 14 May – 10 June 2025

GENERAL INFORMATION

The Union World Conference on Lung Health is pleased to host the 8th edition of TBScience, an official event entirely devoted to basic, clinical and translational science on tuberculosis. TBScience will be held in-person during the Union conference between 18-22 November 2025 in Copenhagen, Denmark.

INFORMATION FOR AUTHORS

TBScience is devoted to basic, clinical and translational science on tuberculosis.

NOTE:

This year we invite submission of all abstracts, irrespective of the conference themes, provided they meet the criteria listed below. Oral abstract presentations will be offered to authors of the highest scoring abstracts in the review process.

Abstracts should:

  1. Contain original data not published at the time of the abstract submission deadline
  2. Focus on any of the following research fields:
    1. basic science (microbiology, immunology, cell biology, etc.);
    2. animal model studies;
    3. clinical research, particularly investigational medicine and product development;
    4. modelling for epidemiology and transmission
  1. Not eligible are abstracts related to:
    1. implementation science;
    2. health systems and policy;
    3. operational and programmatic research;
    4. descriptive epidemiology (e.g. prevalence surveys)
    5. health economics;
    6. social science research
  • All TBScience 2025 abstracts must be submitted online via the dedicated system that will be available from 14 May to 10 June. Abstracts submitted by email or any alternative method will not be considered.
  • Persons submitting TBScience 2025 abstracts will be notified of acceptance or rejection of their submissions by late July 2025.
  • If you represent a UN organisation, please select the name of the organisation from the list available in the drop-down menu.
  • A listed co-author other than the corresponding author may register and present the study at the conference. The corresponding author is responsible for the abstract content. S/he is the contact person for submission and communication purposes and is also responsible for disseminating information related to the session to the co-authors.
  • The presenting author by submitting their abstract agrees to make themselves (or a colleague) available during the conference for a virtual question and answer session/ poster tour/ and or record a short presentation that can be placed online within the conference platform.
  • The maximum number of authors and institutions is eight.
  • If all authors belong to a single institution, you do not need to create new affiliations for each author.
  • When submitting, click on “Institutes” to fill in the affiliation fields.
ABSTRACT INFORMATION

TEXT

  • The abstract should be in English, and no more than 300 words.
  • Type the title of the abstract in upper and lower case, using capitals only for the first word, acronyms and proper nouns.
  • Titles of more than 25 words (110 characters and spaces) will be truncated.
  • One table or one figure may be included with the abstract.
  • If you wish to submit a table with your abstract, note that it should be no larger than 5 rows by 10 columns.
  • If you wish to submit a figure with your abstract, note the maximum file size of each graph/image is 5 MB. The maximum pixel size of the graph is 600(w) x 800(h). You may upload graphs in JPG, GIF or PNG format.
  • Recommended resolution: min. 150 dpi, 300 dpi for images, 600 dpi for line art (charts).
  • Important: the graphic content must be clearly legible when previewing the abstract.
  • Low-resolution images will not be included in the Abstract Book.
  • Please note that tables and figures are reproduced in a single column with the abstract and that legibility is the responsibility of the author.
  • We recommend that you use a sans serif (Arial or Calibri) font for clarity.
  • Use the palette of characters provided to insert symbols, accents and special formatting (e.g., italics, bold, β, μ, etc.).
  • Abbreviations and acronyms must be written out in full at the first mention in the text.
  • Authors are responsible for proofreading and submitting an abstract without errors.

 

 ORGANISATION

  • Authors are given flexibility with regards to the structure of their abstract.
  • No imposed abstract sections such as Background, Methods, Results and Conclusions are required.
  • It is the responsibility of the author to present the abstract in a cohesive way.

 

USE OF NON-STIGMATISING LANGUAGE         

  • The Union is committed to promoting patient-centred language
  • When drafting your abstract, please follow the guidance laid out by the Stop TB – link
SUBMISSION PROCESS

SUBMITTING AN ABSTRACT

  • To submit a new abstract, create a user account on the abstract submission platform
  • Ensure that you carefully read all instructions given on the screen at each step of the process.
  • Do not upload the text of your abstract as an attachment. Abstracts submitted as attachments will not be considered.
  • Please refrain from submitting multiple abstracts on the same topic by varying the authors or under different titles with only minor word changes. In such cases, all of the submissions on that topic will be automatically rejected.
POST-SUBMISSION
  • The corresponding author will receive an email confirming that the submitted abstract has been received successfully, with an attachment of the submission.
  • After the abstract has been submitted, it can still be edited. However, please make sure that you submit it in its final version before the deadline.


REVIEW

  • All submitted abstracts will be sent for peer review by a panel of international experts.
  • The scores will then be submitted to the Scientific Committee. Note that decisions of the abstract review committee are final and cannot be appealed.

 

NOTIFICATION

  • Corresponding authors will be notified of acceptance of their abstracts by end of July.
  • Abstracts that are not accepted cannot be reconsidered for review or presentation at the conference.

 

TO INCLUDE WITH APPLICATION:

  • Confirmation that the work has not been previously submitted for consideration to the general portion of the Union World Conference.
  • The address, phone and email address where the author may be contacted.
  • Information if you require a scholarship to register for the conference.

Abstract Reviewing Guidelines

REVIEWING

All submitted abstracts are sent for peer review by a panel of international experts. The panel will score abstracts based on the following criteria. The TBScience 2025 Scientific Committee will then base their programme selection decisions upon the results of the reviewing process:

 

CRITERIADESCRIPTIONSCORING RANGESCORING
1. Novelty/ OriginalityThe abstract shows novel/original information or presents a new topic or application in the TBScience field.1-51=very poor;
2=poor;
3=average;
4=above average;
5=excellent
2. ClarityThe abstract is written in a clear and concise way and hasa good structure;1-51=very poor;
2=poor;
3=average;
4=above average;
5=excellent
3. Significance/ impact/relevance to the TBScience field

The abstract describes research results/new findings, methods or approaches that are significant/have impact/relevance to the TBScience field

1-51=very poor;
2=poor;
3=average;
4=above average;
5=excellent
4. Quality of the Methodology

The methods presented in the abstract are of high quality

1-51=very poor;
2=poor;
3=average;
4=above average;
5=excellent

Maximum score: 20

NOTIFICATIONS

Abstract submitters will be notified of acceptance/rejection by end of July 2025.